LAG3 and head and neck squamous cell carcinoma: Interestingly, this observation was not detected in other pathways, such as PD-1 and CTLA-4, and appears to be specific to LAG-3, suggesting that HPV-associated HNSCC may benefit significantly from LAG-3 blockade (Panda et al., 2020).